Glymphatic system
A waste-clearance pathway of the central nervous system in which cerebrospinal fluid flows along perivascular spaces to remove metabolic waste. Its activity increases markedly during deep sleep.
Timeline (last 90 days)
The glymphatic clearance hypothesis faces controversy: imaging methods vary in reproducibility across laboratories; the causal relationship between AQP4 polarity loss and disease progression has not been fully established; and there is a lack of large-scale human trial evidence on whether enhancing glymphatic clearance can truly improve clinical outcomes.
The glymphatic system is a fluid transport network in the central nervous system responsible for clearing metabolic waste, composed mainly of meningeal lymphatic vessels, perivascular spaces, and aquaporin-4 (AQP4) on astrocyte endfeet.
Enhancing glymphatic clearance is more specifically targeted at vasogenic edema (increased interstitial fluid), while its direct effect on cytotoxic edema remains unclear.
When AQP4 polarity is lost (such as in aging, ischemia or neurodegenerative disease), glymphatic flow rate drops significantly.
The glymphatic system differs from the lymphatic system: it does not transport immune cells, but instead uses the exchange between cerebrospinal fluid and brain interstitial fluid to drain metabolic products such as beta-amyloid and tau protein out of the brain.
The glymphatic system is the waste clearance pathway of the central nervous system, which mainly carries metabolic waste (including beta-amyloid) out of brain tissue through the flow of cerebrospinal fluid along perivascular spaces.
The clearance of beta-amyloid depends heavily on glymphatic system activity during deep sleep.
Glymphatic system activity is significantly enhanced during deep sleep, while its efficiency declines during wakefulness or fragmented sleep.
The glymphatic system is a brain waste-clearance mechanism discovered by the scientific community in 2013; it is primarily active during sleep and removes metabolic waste products such as β-amyloid and tau proteins through cerebrospinal fluid flow
During deep non-rapid eye movement (NREM) sleep, the brain's glymphatic system clears metabolic waste products, including β-amyloid associated with Alzheimer's disease.
3 more timeline events
All Facts (13)
The glymphatic clearance hypothesis faces controversy: imaging methods vary in reproducibility across laboratories; the causal relationship between AQP4 polarity loss and disease progression has not been fully established; and there is a lack of large-scale human trial evidence on whether enhancing glymphatic clearance can truly improve clinical outcomes.
50%UnverifiedThe glymphatic system is a fluid transport network in the central nervous system responsible for clearing metabolic waste, composed mainly of meningeal lymphatic vessels, perivascular spaces, and aquaporin-4 (AQP4) on astrocyte endfeet.
50%UnverifiedEnhancing glymphatic clearance is more specifically targeted at vasogenic edema (increased interstitial fluid), while its direct effect on cytotoxic edema remains unclear.
50%UnverifiedWhen AQP4 polarity is lost (such as in aging, ischemia or neurodegenerative disease), glymphatic flow rate drops significantly.
50%UnverifiedThe glymphatic system differs from the lymphatic system: it does not transport immune cells, but instead uses the exchange between cerebrospinal fluid and brain interstitial fluid to drain metabolic products such as beta-amyloid and tau protein out of the brain.
50%UnverifiedThe glymphatic system is the waste clearance pathway of the central nervous system, which mainly carries metabolic waste (including beta-amyloid) out of brain tissue through the flow of cerebrospinal fluid along perivascular spaces.
50%UnverifiedThe clearance of beta-amyloid depends heavily on glymphatic system activity during deep sleep.
50%UnverifiedGlymphatic system activity is significantly enhanced during deep sleep, while its efficiency declines during wakefulness or fragmented sleep.
50%UnverifiedThe glymphatic system is a brain waste-clearance mechanism discovered by the scientific community in 2013; it is primarily active during sleep and removes metabolic waste products such as β-amyloid and tau proteins through cerebrospinal fluid flow
50%UnverifiedDuring deep non-rapid eye movement (NREM) sleep, the brain's glymphatic system clears metabolic waste products, including β-amyloid associated with Alzheimer's disease.
50%UnverifiedA positive amyloid pathology biomarker does not mean an individual will necessarily develop Alzheimer's disease dementia, and there is a risk of overdiagnosis.
50%Unverified类淋巴系统（glymphatic system）的概念由丹麦神经科学家Maiken Nedergaard于2012年首次提出
50%Unverified类淋巴系统依赖胶质细胞（glia）发挥类似外周淋巴系统的功能，在深度睡眠期间活性最高
50%